Associations of salivary cortisol levels with inflammatory markers: The Multi-Ethnic Study of Atherosclerosis

Psychoneuroendocrinology

Volumn 37, Issue 7, 2012, Pages 1009-1018

  DeSantis, A S ^a   DiezRoux, A V ^a   Hajat, A ^a   Aiello, A E ^a   Golden, S H ^b   Jenny, N S ^c   Seeman, T E ^d   Shea, S ^e  

^a UNIVERSITY OF MICHIGAN   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c UNIVERSITY OF VERMONT   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e Howard Hughes Medical Institute   (United States)

Author keywords

Cortisol; Cytokines; HPA axis; Inflammation

Indexed keywords

HYDROCORTISONE; INTERLEUKIN 10; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; AROUSAL; ARTICLE; ATHEROSCLEROSIS; FEMALE; HORMONE ACTION; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INFLAMMATION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MENTAL STRESS; POPULATION RESEARCH; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; RISK FACTOR; SALIVA LEVEL; WAKEFULNESS;

AGED; AGED, 80 AND OVER; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; ETHNIC GROUPS; FEMALE; HUMANS; HYDROCORTISONE; INFLAMMATION; INTERLEUKIN-6; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; OBESITY; OVERWEIGHT; SALIVA;

EID: 84861199840     PISSN: 03064530     EISSN: 18733360     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2011.11.009     Document Type: Article

References (53)

1. Adam E.K., Gunnar M.R. Psychoneuroendocrinology 2001, 26:189-208.
2. Adam E.K., Hawkley L.C., Kudielka B.M., Cacioppo J.T. Day-to-day dynamics of experience-cortisol associations in a population-based sample of older adults. PNAS USA 2006, 17058-17063.
3. Anagnostis P., Athyros V.G., Tziomalos K., Karagiannis A., Mikhailidis D.P. Clinical review: the pathogenetic role of cortisol in the metabolic syndrome: a hypothesis. J. Clin. Endocrinol. Metab. 2009, 94:2692-2701.
4. Badrick E., Kirschbaum C., Kumari M. The relationship between smoking status and cortisol secretion. J. Clin. Endocrinol. Metab. 2007, 92:819-824.
5. Barefoot J.C., Dodge K.A., Peterson B.L., Dahlstrom W.G., Williams R.B. The Cook-Medley hostility scale: item content and ability to predict survival. Psychosom. Med. 1989, 51:46-57.
6. Bild D.E., Bluemke D.A., Burke G.L., Detrano R., Diez Roux A.V., Folsom A.R., et al. Multi-Ethnic Study of Atherosclerosis: objectives and design. Am. J. Epidemiol. 2002, 156:871-881.
7. Black P.H. The inflammatory response is an integral part of the stress response: implications for atherosclerosis, insulin resistance, type II diabetes and metabolic syndrome X. Brain Behav. Immun. 2003, 17:350-364.
8. Bower J.E., Ganz P.A., Dickerson S.S., Petersen L., Aziz N., Fahey J.L. Diurnal cortisol rhythm and fatigue in breast cancer survivors. PNEC 2005, 30:92-100.
9. Bromberger J.T., Matthews K.A. A longitudinal study of the effects of pessimism, trait anxiety, and life stress on depressive symptoms in middle-aged women. Psychol. Aging 1996, 11:207-213.
10. Chrousos G.P. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. NEJM 1995, 332:1351-1362.
11. Clow A., Thorn L., Evans P., Hucklebridge F. The awakening cortisol response: methodological issues and significance. Stress 2004, 7:29-37.
12. Cohen S., Schwartz J.E., Epel E., Kirschbaum C., Sidney S., Seeman T. Socioeconomic status, race and diurnal cortisol decline in the coronary artery risk development in young adults (CARDIA) study. Psychosom. Med. 2006, 68:41-50.
13. Curtin N.M., Mills K.H., Connor T.J. Psychological stress increases expression of IL-10 and its homolog IL-19 via beta-adrenoceptor activation: reversal by the anxiolyticchlordiazepoxide. Brain Behav. Immun. 2009, 23:371-379.
14. DeRijk R., Michelson D., Karp B., Petrides J., Galliven E., Deuster P., Paciotti G., Gold P.W., Sternberg E.M. Exercise and circadian rhythm-induced variations in plasma cortisol differentially regulate interleukin-1ß (IL-1ß), IL-6, and tumor necrosis factor-(TNF) production in humans: high sensitivity of TNF and resistance of IL-6. J. Clin. Endocrinol. Metab. 1997, 82:2182-2191.
15. DeSantis A.S., Adam E.K., Doane L.D., Mineka S., Zinbarg R.E., Craske M.E. Racial and ethnic differences in cortisol diurnal rhythms in a community sample of adolescents. J. Adolesc. Health 2007, 41:3-13.
16. Dickerson S.S., Kemeny M.E. Acute stressors and cortisol responses: a theoretical integration and synthesis of laboratory research. Psychol. Bull. 2004, 130:355-391.
17. Elenkov I.J. Neurohormonal-cytokine interactions: implications for inflammation, common human diseases and well-being. NeurochemInt 2008, 52:40-51.
18. Elenkov I.J., Chrousos G.P. Stress hormones, pro-inflammatory and anti-inflammatory cytokines, and autoimmunity. Ann. N.Y. Acad. Sci. 2002, 966:290-303.
19. Elenkov I.J., Chrousos G.P. Stress hormones, Th1/Th2 patterns, pro/anti-inflammatory cytokines and susceptibility to disease. Trends Endocrinol. Metab. 1999, 10:359-368.
20. ENRICHD Investigators Enhancing recovery in Coronary Heart Disease patients (ENRICHD): study design and methods. Am. Heart J. 2000, 139:1-9.
21. Feghali C.A., Wright T.M. Cytokines in acute and chronic inflammation. Front. Biosci. 1997, 2:d12-d26.
22. Gimeno D., Brunner E.J., Lowe G.D.O., Rumley A., Marmot M.E., Ferrie J.E. Adult socioeconomic position, C-reactive protein and interleukin-6 in the Whitehall II prospective study. Eur. J. Epidemiol. 2007, 22:675-683.
23. Gunnar M.R., Vazquez D.M. Dev. Psychopathol. 2001, 13:515-538.
24. Hajat A., Diez Roux A.V., Franklin T.G., Seeman T., Shrager S., Ranjit N., Castro C., Watson K., Sanchez B.N., Kirschbaum C. Socioeconomic and race/ethnic differences in daily salivary cortisol profiles: The Multiethnic Study of Atherosclerosis. PNEC 2010, 35:932-943.
25. Heim C., Newport D.J., Mletzko T., Miller A.H., Nemeroff C.B. The link between childhood trauma and depression: insights from HPA axis studies in humans. PNEC 2008, 33:693-710.
26. Kiecolt-Glaser J.K., McGuire L., Robles T., Glaser R. Psychoneuroimmunology: psychological influences on immune function and health. J. Consult. Clin. Psych. 2002, 70:537-547.
27. Kiecolt-Glaser J.K., Preacher K.J., MacCallum R.C., Atkinson C., Malarkey W.B., Glaser R. Chronic stress and age-related increases in the proinflammatory cytokine IL-6. PNAS USA 2003, 100:9090-9095.
28. Kirschbaum C., Hellhammer D.H. Salivary cortisol in psycho-biological research: an overview. Neuropsychobiology 1989, 22:150-169.
29. Koster A., Bosma H., Penninx B., Newman A.B., Harris T.B., van Eijk J.T., Kempen G.I., Simonsick E.M., Johnson K.C., Rooks R.N., Ayonayon H.N., Rubin S.M., Kritchevsky S.B., Health ABC Study Association of inflammatory markers with socioeconomic status. J. Gerontol. A. Biol. Sci. Med. Sci. 2006, 61:284-290.
30. Kudielka B.M., Broderick J.E., Kirschbaum C. Compliance with saliva sampling protocols: electronic monitoring reveals invalid cortisol daytime profiles in noncompliant subjects. Psychosom. Med. 2003, 65:313-319.
31. Kumari M., Badrick E., Chandola T., Adam E.K., Stafford M., Marmot M.G., Kirschbaum C., Kivimaki M. Cortisol secretion and fatigue: associations in a community based cohort. PNEC 2009, 34:1476-1485.
32. Maes M., Lin E., Delmeire L. Elevated serum interleukin-6 (IL-6) and IL-6 receptor concentrations in posttraumatic stress disorder following accidental man-made traumatic events. Biol. Psychiatry 1999, 45:833-839.
33. Maes M., Song C., Lin A., De Jongh R. The effects of psychological stress on humans: increased production of pro-inflammatory cytokines and Th1-like response in stress-induced anxiety. Cytokine 1998, 10:313.
34. McEwen B.S., Biron C.A., Brunson K.W., Bulloch K., Chambers W.H., Dhabhar F.S., Goldfarb R.H., Kitson R.P., Miller A.H., Spencer R.L., Weiss J.M. The role of adrenocorticoids as modulators of immune function in health and disease: neural, endocrine and immune interactions. Brain Res. Rev. 1997, 23:79-133.
35. Miller G.E., Cohen S., Ritchey A.K. Chronic psychological stress and the regulation of pro-inflammatory cytokines: a glucocorticoid-resistance model. Health Psychol. 2002, 21:531-541.
36. Moore K.W., de Waal Malefyt R., Coffman R.L., O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 2001, 19:683-765.
37. Nater U.M., Youngblood L.S., Jones J.F., Unger E.R., Miller A.H., Reeves W.C., Heim C. Alterations in diurnal salivary cortisol rhythm in a population-based sample of cases with chronic fatigue syndrome. Psychosom. Med. 2008, 70:298-305.
38. Nijm J., Jonasson L. Inflammation and cortisol response in coronary artery disease. Ann. Med. 2009, 41:224-233.
39. Perry M.G., Kirwan J.R., Jessop D.S., Hunt L.P. Overnight variations in cortisol, interleukin 6, tumour necrosis factor alpha and other cytokines in people with rheumatoid arthritis. Ann. Rheum. Dis. 2009, 68:63-68.
40. Petrovsky N., McNair P., Harrison L.C. Diurnal rhythms of pro-inflammatory cytokines: regulation by plasma cortisol and therapeutic implications. Cytokine 1998, 10:307-312.
41. Picotte M., Campbell C.G., Thorland W.G. Day-to-day variation in plasma interleukin-6 concentrations in older adults. Cytokine 2009, 47:162-165.
42. Pruessner J.C., Wolf O.T., Hellhammer D.H., Buske-Kirschbaum A., von Auer K., Jobst S., Kaspers F., Kirschbaum C. Free cortisol levels after awakening: a reliable biological marker for the assessment of adrenocortical activity. Life Sci. 1997, 61:2539-2549.
43. Radloff L. The CES-D scale: a self-report depression scale for research in the general population. Appl. Psychol. Meas. 1977, 1:385-401.
44. Ramsay S., Lowe G.D., Whincup P.H., Rumley A., Morris R.W., Wannamethee S.G. Relationships of inflammatory and haemostatic markers with social class: results from a population-based study of older men. Atherosclerosis 2008, 197:654-661.
45. Ranjit N., Diez-Roux A.V., Sanchez B., Seeman T., Shea S., Shrager S., Watson K. Association of salivary cortisol circadian pattern with cynical hostility: Multi-Ethnic Study of Atherosclerosis. Psychosom. Med. 2009, 71:748-755.
46. Ranjit N., Diez Roux A.V., Shea S., Cushman M., Ni H., Seeman T. Socioeconomic position, race/ethnicity, and inflammation in the Multiethnic Study of Atherosclerosis. Circulation 2007, 116:2383-2390.
47. Riechlin S. Neuroendocrine-immune interactions. NEJM 1993, 329:1246-1253.
48. Sapolsky R.M., Krey L.C., McEwen B.S. The neuroendocrinology of stress and aging: the glucocorticoid cascade hypothesis. Endocr. Rev. 1986, 7:284-301.
49. Sapolsky R.L., Romero M., Munck A.U. How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions. Endocr. Rev. 2000, 21:55-89.
50. Segerstrom S.C., Miller G.E. Psychological stress and the human immune system: a meta-analytic study of 30 years of inquiry. Psychol. Bull. 2004, 130:601-630.
51. Sephton S.E., Sapolsky R., Kraemer H.C., Spiegel D. Diurnal cortisol rhythm as a predictor of breast cancer survival. J. Natl. Cancer Inst. 2000, 92:994-1000.
52. Steensburg A., Fischer C.P., Keller C., Møller K., Pedersen B.K. IL-6 enhances plasma IL-1ra, IL-10, and cortisol in humans. Am. J. Physiol. Endocrinol. Metab. 2003, 285:E433-E437.
53. Sternberg E.M. Neuroendocrine regulation of autoimmune/inflammatory disease. J. Endocrinol. 2001, 169:429-435.